Addressing Social Drivers of Health to Improve Patient Outcomes with Dr. Greg Carroll ClinNEXUS TRANSCRIPT
Release Date: 08/10/2026
Smart Hearing Aids Hearing Loss and Cognitive Decline with Dr. Rachel Artsma Hear.com TRANSCRIPT
Empowered Patient Podcast
Dr. Rachel Artsma, lead audiologist at hear.com offers comprehensive hearing care services and she emphasizes how dramatically hearing aids have evolved from earlier generations. Bluetooth connectivity, rechargeable batteries, and real-time environmental adjustments are now being driven by smart chips in the devices, which also allow direct streaming of phone calls, music, and driving directions. Untreated hearing loss can lead to auditory deprivation, in which the brain does not receive clear auditory input, resulting in increased cognitive strain and a decline in cognitive function. Rachel...
info_outline
Smart Hearing Aids Hearing Loss and Cognitive Decline with Dr. Rachel Artsma Hear.com
Empowered Patient Podcast
Dr. Rachel Artsma, lead audiologist at hear.com offers comprehensive hearing care services and she emphasizes how dramatically hearing aids have evolved from earlier generations. Bluetooth connectivity, rechargeable batteries, and real-time environmental adjustments are now being driven by smart chips in the devices, which also allow direct streaming of phone calls, music, and driving directions. Untreated hearing loss can lead to auditory deprivation, in which the brain does not receive clear auditory input, resulting in increased cognitive strain and a decline in cognitive function. Rachel...
info_outline
Parkinson’s Disease Management Transformed by AI-Powered Longitudinal Tracking with Amy Gordon Franzen Rune Labs TRANSCRIPT
Empowered Patient Podcast
Amy Gordon Franzen, CEO of Rune Labs, developed StrivePD, a patient-facing app that supports those with Parkinson's disease by passively tracking their movements and collecting longitudinal data on tremor, gait, and activity patterns. The technology addresses a critical gap in neurodegenerative disease management by providing continuous, objective data that enables patients and clinicians to make more informed treatment decisions. There is also an AI chatbot that allows patients to interrogate their data and receive personalized insights while enabling clinicians and drug developers to...
info_outline
Parkinson’s Disease Management Transformed by AI-Powered Longitudinal Tracking with Amy Gordon Franzen Rune Labs
Empowered Patient Podcast
Amy Gordon Franzen, CEO of Rune Labs, developed StrivePD, a patient-facing app that supports those with Parkinson's disease by passively tracking their movements and collecting longitudinal data on tremor, gait, and activity patterns. The technology addresses a critical gap in neurodegenerative disease management by providing continuous, objective data that enables patients and clinicians to make more informed treatment decisions. There is also an AI chatbot that allows patients to interrogate their data and receive personalized insights while enabling clinicians and drug developers to...
info_outline
Gene Therapy for Treating Root Cause of Severe Food Allergies with Dr. Sid Kerkar AllerGene AI TRANSCRIPT
Empowered Patient Podcast
Dr. Sid Kerkar, CEO and Founder of AllerGene AI Therapeutics, is developing in vivo gene therapy for severe food allergies, where symptoms are currently treated rather than root causes. AllerGene AI is targeting mast cells, which are immune cells responsible for triggering allergic reactions, and their approach represents a significant opportunity to prevent these reactions. Unlike traditional cell therapy, this technology modifies cells within the body to recognize and eliminate armed mast cells, allowing the body to repopulate with non-reactive cells, preventing severe allergic reactions...
info_outline
Gene Therapy for Treating Root Cause of Severe Food Allergies with Dr. Sid Kerkar AllerGene AI
Empowered Patient Podcast
Dr. Sid Kerkar, CEO and Founder of AllerGene AI Therapeutics, is developing in vivo gene therapy for severe food allergies, where symptoms are currently treated rather than root causes. AllerGene AI is targeting mast cells, which are immune cells responsible for triggering allergic reactions, and their approach represents a significant opportunity to prevent these reactions. Unlike traditional cell therapy, this technology modifies cells within the body to recognize and eliminate armed mast cells, allowing the body to repopulate with non-reactive cells, preventing severe allergic reactions...
info_outline
Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health TRANSCRIPT
Empowered Patient Podcast
Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits. The company addresses the gap in post-acute care between hospital care and primary care follow-up by proactive monitoring, medication management, and pain control. Inspired by the hospitalist model, Dimer is defining a transitionist model that is tailored to each patient's needs and home environment, intervening early on minor complications to reduce...
info_outline
Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health
Empowered Patient Podcast
Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits. The company addresses the gap in post-acute care between hospital care and primary care follow-up by proactive monitoring, medication management, and pain control. Inspired by the hospitalist model, Dimer is defining a transitionist model that is tailored to each patient's needs and home environment, intervening early on minor complications to reduce...
info_outline
Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran TRANSCRIPT
Empowered Patient Podcast
Sharon Blank, CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks. The organization works with pharmacies to deliver translations created by native-speaking pharmacists rather than by automated systems or untrained interpreters. As this LEP population grows, RxTran advocates for standardized, human-verified translation practices to ensure healthcare access and patient safety across all populations. Sharon explains, "So RxTran’s...
info_outline
Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran
Empowered Patient Podcast
Sharon Blank, CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks. The organization works with pharmacies to deliver translations created by native-speaking pharmacists rather than by automated systems or untrained interpreters. As this LEP population grows, RxTran advocates for standardized, human-verified translation practices to ensure healthcare access and patient safety across all populations. Sharon explains, "So RxTran’s...
info_outlineDr. Greg Carroll, emergency physician and Co-Founder and CEO of ClinNEXUS, a data-first healthcare company addressing social drivers of health in underserved communities by breaking down data silos. Integrating clinical information with social, behavioral, and environmental factors and using AI to augment human care coordinators enables them to identify patient needs proactively and provide personalized support. The model emphasizes building trust through in-person engagement while leveraging digital tools to enhance the care manager's ability to process complex data and deliver real-time insights.
Greg explains, "We're a data-first company that is focused on improving healthcare outcomes for underserved communities. That's pretty broad. But if you think about traditional healthcare, especially in the United States, if you look at 20% of patients or individuals driving about 80% of costs in healthcare. And traditional healthcare has not been able to really put a dent in this over time. And really the reason is that traditional healthcare has not addressed the true drivers of people's health, especially in underserved communities."
"Traditional healthcare has not done a good job of addressing those non-clinical issues, and it's done an even worse job of orchestrating and ensuring that across all those dimensions, we're addressing people's health. And so, in terms of the mission, it's about breaking down the silos in people's care and in the data available to those who support them. Making sure we're looking at all dimensions of people's health and helping them navigate to live happier, healthier lives, especially for communities facing many of the challenges I've mentioned."
#ClinNEXUS #HealthcareInnovation #PopulationHealth #SocialDriversOfHealth #CareCoordination #AIinHealthcare #Medicaid #ValueBasedCare
